Filed before 2025Filed 9 February 2017
Tarveda Therapeutics, Inc. has sold $38M so far
Tarveda Therapeutics, Inc., a biotech company based in Watertown, MA, has sold $38M so far in its equity round, according to a filing dated 9 February 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 February 2017
- First filed
- 29 January 2016
- Round
- Equity round (amended filing)
- Amount sold
- $38M
- Offering size
- $38M
- Investors so far
- 8
- Based in
- Watertown, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,645 tracked raises with an amount filed in 2017, and than 84% of the 152 in biotech.
Tarveda Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 26 Dec 2019 | New filing | $13.6M | Another raise |
| 9 Feb 2017 | New filing | $30M | Another raise |
| 9 Feb 2017 | Amended filing | $38M | This raise |
| 29 Jan 2016 | New filing | $25.5M | This raise |
| 12 Mar 2014 | New filing | $1000K | Another raise |
More with Kendall Capital on the board
- Noveome Biotherapeutics, Inc.$6.75M
- Rejuvenate Bio Inc$19.5M
- EpiBone, Inc.$4.29M
- VitaKey Inc.Undisclosed
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.